Is vancomycin excreted by the liver?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vancomycin Excretion Pathway

Vancomycin is primarily excreted by the kidneys through glomerular filtration, not by the liver. About 75% of an administered dose is excreted unchanged in urine within the first 24 hours in patients with normal renal function 1.

Pharmacokinetics of Vancomycin

Renal Excretion

  • Approximately 75% of administered vancomycin is excreted unchanged in urine by glomerular filtration within the first 24 hours in patients with normal renal function 1
  • Mean plasma clearance is about 0.058 L/kg/h, and mean renal clearance is about 0.048 L/kg/h 1
  • The elimination half-life of vancomycin from plasma is 4-6 hours in subjects with normal renal function 1
  • Renal dysfunction significantly slows excretion of vancomycin, with the average half-life increasing to 7.5 days in anephric patients 1

Metabolism and Hepatic Processing

  • There is no apparent metabolism of vancomycin 1
  • Unlike many other antibiotics, vancomycin does not undergo significant hepatic metabolism 2
  • When administered intravenously, vancomycin is excreted primarily unchanged in the urine by glomerular filtration 2

Clinical Implications

Dosing Considerations

  • Vancomycin dosage must be adjusted in patients with renal impairment due to its primary renal excretion pathway 3
  • Intravenous vancomycin has no effect on Clostridioides difficile infection since the antibiotic is not excreted into the colon 4
  • For treatment of C. difficile infection, oral vancomycin is preferred as it remains in the gut lumen and is not significantly absorbed systemically 4

Liver Disease Considerations

  • In patients with liver disease and normal renal function, total clearance of vancomycin is generally not affected 5
  • In patients with both impaired liver and renal functions, particularly with obstructive jaundice, the unbound fraction of vancomycin may increase while renal excretion is delayed 5
  • Caution should be exercised when administering conventional doses of vancomycin to patients with combined hepatic and renal dysfunction as blood concentrations may increase excessively 5

Protein Binding and Distribution

  • Vancomycin is approximately 55% serum protein bound at concentrations of 10-100 mcg/mL 1
  • The distribution coefficient ranges from 0.3 to 0.43 L/kg 1
  • After IV administration, inhibitory concentrations are present in pleural, pericardial, ascitic, and synovial fluids; in urine; in peritoneal dialysis fluid; and in atrial appendage tissue 1

Special Considerations

  • Total systemic and renal clearance of vancomycin may be reduced in elderly patients 1
  • Vancomycin does not readily cross normal meninges but can penetrate into spinal fluid when meninges are inflamed 1
  • About 60% of an intraperitoneal dose of vancomycin administered during peritoneal dialysis is absorbed systemically in 6 hours 1

Understanding vancomycin's primarily renal excretion pathway is crucial for appropriate dosing and monitoring, especially in patients with impaired renal function where dose adjustments are necessary to prevent toxicity.

References

Research

Vancomycin: an update.

Pharmacotherapy, 1986

Research

Pharmacokinetics of vancomycin.

The Journal of antimicrobial chemotherapy, 1984

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Study of the pharmacokinetics of vancomycin in patients with impaired liver function.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.